Company* | Company* (Country) | Type/Product Area | Terms/Details (Date) |
| |||
Agilent | IBM Corp. | Agreement to develop an informatics system designed to aid in drug discovery and development | The companies will collaborate to make IBM's DiscoveryLink data integration technology compatible with Agilent's Synapsia informatics Workbench software family (8/21) |
AxCell Bio- | IBM Corp. | Agreement in which AxCell is using the DB2 database technology of IBM to help chart communication pathways within cells that enable proteins to interact and cause or prevent diseases | AxCell also will augment its internal data mining system with IBM DiscoveryLink data integration software (8/16) |
Incyte Genomics | TimeLogic | Agreement to integrate TimeLogic's bioinformatics system, DeCypher, into Incyte's LifeSeq Foundation information product | Financial terms were not disclosed (8/22) |
Genomatica | The Dow | Research agreement to use Genomatica's SimPheny modeling platform to develop an in silico metabolic model for Dow's use in microbial metabolism and bioprocess modeling | Financial terms were not disclosed but include research support and milestone payments (9/18) |
PNP | Mayne Group | Exclusive agreement to license its patented cell-killing gene technology that is a component in Mayne's prostate cancer treatment, FP253 | Mayne will combine PNP's technology with other technology licensed from an Australian research organization (8/23) |
Qiagen NV | Precision | Agreement to purchase certain automation components for Qiagen's automated nucleic acid, protein and cell purification solutions from Precision Systems Science | Certain components will be available on an exclusive basis (8/16) |
Sequenom | Samsung Advanced Institute of Technology | Research agreement for genome-wide screens to identify potential disease-related markers | SAIT plans to use the markers to develop its biochips; Sequenom and SAIT will share commercial rights to disease-gene discoveries and other intellectual property generated in the collaboration (6/18) |
Third Wave Technologies | PointOne | Collaboration on an application of genetic medicine for cardiovascular care | The program will use genetic data to develop individualized patient care plans designed to prevent the occurrence or advancement of cardiovascular disease (8/6) |
TurboGenomics | IBM Life | Collaboration to combine IBM infrastructure software and TurboGenomics tools for distributing application workloads and managing work flows across computing clusters and grids | TurboGenomics' bioinformatics tools will become components of the IBM Life Sciences Framework (9/4) |
| |||
Notes: | |||
# This chart does not include agreements that involve agricultural product development. | |||
* Private companies are indicated with an asterisk. | |||
Unless otherwise noted, the trading symbols listed for public companies are on the Nasdaq market. | |||
NYSE = New York Stock Exchange |